Detalhe da pesquisa
1.
Targeting and monitoring ovarian cancer invasion with an RNAi and peptide delivery system.
Proc Natl Acad Sci U S A
; 121(11): e2307802121, 2024 Mar 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38437557
2.
SMARCE1 is required for the invasive progression of in situ cancers.
Proc Natl Acad Sci U S A
; 114(16): 4153-4158, 2017 04 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-28377514
3.
Chemerin suppresses hepatocellular carcinoma metastasis through CMKLR1-PTEN-Akt axis.
Br J Cancer
; 118(10): 1337-1348, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29717200
4.
RACK1 promotes non-small-cell lung cancer tumorigenicity through activating sonic hedgehog signaling pathway.
J Biol Chem
; 287(11): 7845-58, 2012 Mar 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-22262830
5.
Sorafenib suppresses postsurgical recurrence and metastasis of hepatocellular carcinoma in an orthotopic mouse model.
Hepatology
; 53(2): 483-92, 2011 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-21274870
6.
Glutamine synthetase licenses APC/C-mediated mitotic progression to drive cell growth.
Nat Metab
; 4(2): 239-253, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35145325
7.
Liver cancer: EphrinA2 promotes tumorigenicity through Rac1/Akt/NF-kappaB signaling pathway.
Hepatology
; 51(2): 535-44, 2010 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-19918976
8.
Transcriptional Control of Metastasis by Integrated Stress Response Signaling.
Front Oncol
; 11: 770843, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34746012
9.
Breast tissue regeneration is driven by cell-matrix interactions coordinating multi-lineage stem cell differentiation through DDR1.
Nat Commun
; 12(1): 7116, 2021 12 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34893587
10.
BCL9/BCL9L promotes tumorigenicity through immune-dependent and independent mechanisms in triple negative breast cancer.
Oncogene
; 40(16): 2982-2997, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33767438
11.
Liver cancer: WISP3 suppresses hepatocellular carcinoma progression by negative regulation of ß-catenin/TCF/LEF signalling.
Cell Prolif
; 52(3): e12583, 2019 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-30793395
12.
Career pathways, part 12.
Nat Metab
; 5(10): 1642-1645, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37794202
13.
Cancer-specific PERK signaling drives invasion and metastasis through CREB3L1.
Nat Commun
; 8(1): 1079, 2017 10 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-29057869
14.
Author Correction: Glutamine synthetase licenses APC/C-mediated mitotic progression to drive cell growth.
Nat Metab
; 4(6): 791, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-35637348
15.
Hepatocellular carcinoma: thyroid hormone promotes tumorigenicity through inducing cancer stem-like cell self-renewal.
Sci Rep
; 6: 25183, 2016 05 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-27174710
16.
The endoplasmic reticulum may be an Achilles' heel of cancer cells that have undergone an epithelial-to-mesenchymal transition.
Mol Cell Oncol
; 1(2): e961822, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-27308337
17.
Epithelial-to-mesenchymal transition activates PERK-eIF2α and sensitizes cells to endoplasmic reticulum stress.
Cancer Discov
; 4(6): 702-15, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24705811
18.
EphB3 suppresses non-small-cell lung cancer metastasis via a PP2A/RACK1/Akt signalling complex.
Nat Commun
; 3: 667, 2012 Feb 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-22314363
19.
EphB3 is overexpressed in non-small-cell lung cancer and promotes tumor metastasis by enhancing cell survival and migration.
Cancer Res
; 71(3): 1156-66, 2011 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-21266352